Filter Results
:
(141)
Show Results For
-
All HBS Web
(141)
- News (44)
- Research (87)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
Show Results For
-
All HBS Web
(141)
- News (44)
- Research (87)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand the anguish of seriously ill...
View Details
- 01 Dec 2007
- News
Letters to the Editor
while on the faculty here; indeed, our ongoing collaboration has enriched my research and teaching immeasurably. Amy C. Edmondson (PhDOB ’96) Novartis Professor of Leadership and Management Harvard Business School, Boston, MA Schumpeter...
View Details
- 01 Jun 2001
- News
Up Side Story: HBS Show a Sold-Out Success
’01) took care of the creative aspects, including running auditions and rehearsals. Premier sponsors Novartis and The Boston Consulting Group helped offset the $55,000 cost of the show, as did the sales of some 2,400 tickets to students,...
View Details
- 17 Jul 2009
- Research Event
Business Summit: Ethics in Globalization
Mossavar-Rahmani Center for Business and GovernmentMichael Oxley, Of Counsel, Baker HostetlerDaniel Vasella, Chairman & CEO, Novartis Drawing upon learnings from their work and experiences, the panelists and moderator exchanged views...
View Details
Keywords:
Re: Rafael M. Di Tella
- 24 Jun 2016
- News
Reinventing Pharma
(photo by Claire Pearson for eyeforpharma) (photo by Claire Pearson for eyeforpharma) The newly appointed Global Head of Diversity and Inclusion at Novartis Pharma is bringing ideas from her time at HBS to drive an evolution of the...
View Details
- Web
Faculty - Institute For Strategy And Competitiveness
Lasting Value. He serves on the board of directors of Exxon, Goldman Sachs, and Novartis and is chair of the Global Center for Leadership and Business Ethics. Profile Jay W. Lorsch, Louis Kirstein Professor of Human Relations Jay W....
View Details
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
School Case 415-013 Novartis Pharmaceuticals Corp: Redefining Success in the U.S. (A) Over the course of a tumultuous weekend in April 2010, André Wyss was put in charge of Novartis Pharmaceuticals...
View Details
Keywords:
Sean Silverthorne
- 01 Mar 2007
- News
Daniel Vasella
the test as he methodically refashioned the two old-line chemical companies with disparate corporate cultures into a single entity focused on health care and powered by an innovative approach to R&D. Today, Novartis is one of the world’s...
View Details
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
Fonterra to enhance its competitive position. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/517050-PDF-ENG Harvard Business School Case 717-453 Novartis: A Transformative Deal When Joe Jimenez became CEO of Swiss-based View Details
Keywords:
Carmen Nobel
- 24 Jun 2014
- First Look
First Look: June 24
http://hbr.org/product/mobile-broadband-and-the-telecommunications-industry-in-2011/an/814009-PDF-ENG Harvard Business School Case 314-103 The Novartis Malaria Initiative The Novartis Malaria Initiative was...
View Details
Keywords:
Sean Silverthorne
- 18 Mar 2021
- News
Authentically Leading with Blind Ambition
for Leading in Crisis and True North Groups. Bill has previously served on the boards of Goldman Sachs, Mayo Clinic, ExxonMobil, Target, Novartis and The World Economic Forum USA. In 2014 the Franklin Institute presented Bill with the...
View Details
- Profile
Caitlin Reimers
private/public sector partnerships. There was increasing talk of how the two could work together to address issues; similar to how Novartis worked with the World Health Organization to tackle malaria in developing countries." Cait's...
View Details
- 01 Jun 2012
- News
Faculty Books
Teaming: How Organizations Learn, Innovate, and Compete in the Knowledge Economy by Amy C. Edmondson (Jossey-Bass) The Novartis Professor of Leadership and Management, Edmondson says that organizations thrive, or fail to thrive, based on...
View Details
- 06 May 2019
- Research & Ideas
Consumers Blame Business for Global Health Problems. Can Business Become the Solution?
Every public health crisis—whether it’s the availability of highly addictive opioids or junk food marketing to children—prompts consumers to question how far companies will go for profit. It’s not an unwarranted concern. After all, cigarette makers once used...
View Details
- 29 May 2014
- Research & Ideas
Research Symposium 2014
research going on at Harvard Business School. Held each May on the HBS campus, the event provides the opportunity for a few faculty to share recent work with an audience of doctoral students, HBS staff members, and other professors. This year's featured speakers...
View Details
- 01 Jan 2006
- News
Philip L. Yeo, MBA 1976
lab and the Novartis Institute for Tropical Diseases. But in a much larger sense, Yeo is looking out on Singapore's future-a future he has played a primary role in creating since 1986, first as the longtime chairman of the Economic...
View Details
- 12 Feb 2001
- Research & Ideas
Creating Value Across Borders
Business sat down with HBS associate professor Walter Kuemmerle to discuss the entrepreneurial process in an international setting. Kuemmerle, a Novartis Fellow, holds a joint appointment in Entrepreneurial and Service Management and...
View Details
Keywords:
by Staff
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
year required course in ethics and leadership and values. The case explores some of the ethical issues Novartis faced in developing and marketing the drug. Q: Would you say that the lack of management and opportunities for students is...
View Details
- 18 Feb 2015
- First Look
First Look: February 18
which brought together multiple organizations to enhance agricultural development in rural regions. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/715402-PDF-ENG Harvard Business School Case 715-411 Social Business at Novartis: Arogya Parivar Late in...
View Details
Keywords:
Sean Silverthorne
- 29 Apr 2014
- First Look
First Look: April 29
of the merger's architects and visionary legacy CEO Daniel Vasella. He recognized that the global health care environment would create severe challenges for Novartis in the years ahead and that Novartis...
View Details
Keywords:
Sean Silverthorne